News

News Articles

July 2, 2026

Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
Read more
Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.

March 26, 2026

Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
Read more
New cohort is designed to address gaps in understanding treatment journeys across the full continuum of care. Insights show that consumer health products play a critical part in how individuals understand and manage their skin conditions.

October 17, 2024

Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research
Read more
Evidation and 1upHealth announce a long-term partnership to advance patient-centered, real-world health research.

January 8, 2026

Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
Read more
New AI-enabled data collection platform will drive the development of novel multimodal datasets for biomarker discovery, treatment-response modeling, and foundation models of the immune system.

December 16, 2025

‍Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
Read more
New insights from Evidation’s cardiometabolic health and weight management cohort show what factors shape real-world dosing decisions.

April 1, 2026

Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
Read more
Evidation appoints Dr. Ghazanfar Khan as Chief Medical Officer.

March 6, 2025

Evidation Appoints Leslie Oley Wilberforce as CEO
Read more
Evidation appoints Leslie Oley Wilberforce as CEO. Wilberforce will lead Evidation’s next phase of growth in interactive real-world data and health research.

October 3, 2024

Evidation appoints Phil Johnson as Chief Commercial Officer
Read more
Evidation announces the addition of a new Chief Commercial Officer, Phil Johnson.

September 17, 2024

Trialbee and Evidation partner to accelerate and diversify clinical research recruitment
Read more
Learn how Evidation and Trialbee's joint offering drives enrollment outcomes.

July 15, 2024

Rock Health shares findings from weight care survey with Evidation
Read more
Evidation helped Rock Health conduct surveys that investigated experience and perceptions of a variety of weight care solutions.